Metfolin Tablet contains L-Methyl Folate 1 mg as its active ingredient, a biologically active form of folate essential for numerous physiological processes including DNA synthesis, repair, and methylation. It is primarily indicated for the management of folate deficiency and related conditions such as megaloblastic anemia, particularly in patients with impaired folic acid metabolism due to genetic polymorphisms like MTHFR mutations. Metfolin facilitates the conversion of homocysteine to methionine, thereby reducing elevated homocysteine levels associated with cardiovascular risk. Additionally, it plays a crucial role in supporting neurodevelopment and cognitive function, making it beneficial during pregnancy to prevent neural tube defects and in psychiatric conditions where folate metabolism may be compromised. The tablet is well-absorbed and bypasses the need for enzymatic conversion required by folic acid, ensuring better bioavailability and efficacy. It is generally well-tolerated with minimal adverse effects; however, it should be used under medical supervision, especially in patients with a history of hypersensitivity to folate compounds or those receiving anticonvulsant therapy. Metfolin Tablet is an important therapeutic option for correcting folate deficiency and supporting metabolic functions dependent on adequate folate levels.